Company attributes
Industry
B2X
Founder
Pitchbook URL
Legal Name
Exicure, Inc.0
Legal classification
Number of Employees (Ranges)
11 – 500
Email Address
ksharma@macbiocom.com
Phone Number
+184767317000
Number of Employees
33
Full Address
2430 N. Halsted Street Chicago, IL 60614, USA0
CIK Number
Place of Incorporation
Investors
DUNS Number
9687215350
IRS Number
815,333,0080
Founded Date
2011
0Fax Number
84755664110
Total Funding Amount (USD)
58,400,000
Latest Funding Round Date
September 27, 2017
Competitors
Stock Symbol
XCUR0
Exchange
Board of Directors
Former CEO
Latest Funding Type
NAICS Code
325,4110
CAGE Code
6GGR10
Patents Assigned (Count)
3
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
20,000,000
Market Capitalization
15,200,000
Previous Name
Max-1 Acquisition Corp0
SIC Code
2,8340
Ticker Symbol
XCUR0
Wikidata ID
Exicure is a biotech company that develops nucleic acid-based therapeutics to treat rare and severe genetic diseases and cancer. The company has an SNA technology that enables the delivery of genetically-targeted therapies to a broad range of tissues and cells.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
